This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Tidman, M. J Articles by Duncan, C. Search for Related Content Social Bookmarking                         What's this?

The treatment of necrobiosis lipoidica

Department of Dermatology, Lauriston Building, The Royal Infirmary, Lauriston Place, Edinburgh, EH3 9HA, Scotland, UK, mtidman1{at}staffmail.ed.ac.uk

Catriona Duncan

Department of Dermatology, Lauriston Building, The Royal Infirmary, Lauriston Place, Edinburgh, EH3 9HA, Scotland, UK

Necrobiosis lipoidica is an inflammatory disorder, associated with diabetes mellitus, for which the underlying pathological mechanism is unknown and for which there is no rational therapy. However, benefit has been reported from such different treatment regimens as drugs acting on the haemostatic mechanisms, corticosteroid therapy (topical, intralesional and systemic), enhancers of wound healing, surgery and immunomodulating therapies (including photochemotherapy). This is a review of these treatment options.

Key Words: necrobiosis lipoidica.

The British Journal of Diabetes & Vascular Disease, Vol. 5, No. 1, 37-41 (2005)
DOI: 10.1177/14746514050050010701


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				C. Duncan, M. Zaiada, and I. W Campbell Twenty-five-year follow-up of necrobiosis lipoidica diabeticorum The British Journal of Diabetes & Vascular Disease, January 1, 2005; 5(1): 47 - 48. [PDF]